NCT03182920View on ClinicalTrials.gov

A Study of Lasmiditan in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

August 14, 2017

Study Completion Date

August 14, 2017

Conditions
Healthy
Interventions
DRUG

Lasmiditan

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (2)

32117

Covance Daytona Beach, Daytona Beach

47710

Covance Evansville, Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03182920 - A Study of Lasmiditan in Healthy Participants | Biotech Hunter | Biotech Hunter